DDW Editor Reece Armstrong sits down with Tarek Samad, Lundbeck’s Senior Vice President and Head of Research to discuss AI and supercomputing within the drug discovery industry following the company’s recent agreement with the Danish Centre for AI Innovation (DCAI). In May this year, Lundbeck announced an agreement with the DCAI in which it would […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!